Financials

News Discussions Technicals Forecast Seasonals

KYTX fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of Kyverna Therapeutics, Inc.

Total assets of KYTX for Q3 24 is 339.20 M USD, 6.59% less than the previous Q2 24. And total liabilities increased by 23.23% in Q3 24 to 36.49 M USD.

Q4 '22

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD

Q4 '22

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—